SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-017064
Filing Date
2021-01-26
Accepted
2021-01-26 08:20:01
Documents
14
Period of Report
2021-01-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d117286d8k.htm   iXBRL 8-K 26957
2 EX-99.1 d117286dex991.htm EX-99.1 17424
6 GRAPHIC g117286g0126091510517.jpg GRAPHIC 2462
  Complete submission text file 0001193125-21-017064.txt   172770

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crtx-20210126.xsd EX-101.SCH 3072
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20210126_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20210126_pre.xml EX-101.PRE 10954
7 EXTRACTED XBRL INSTANCE DOCUMENT d117286d8k_htm.xml XML 3237
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38890 | Film No.: 21551765
SIC: 2836 Biological Products, (No Diagnostic Substances)